Genetic approach to the role of cysteine proteases in the expansion of abdominal aortic aneurysms

British Journal of Surgery

Volumn 91, Issue 1, 2004, Pages 86-89

  Eriksson, P ^a   Jones, K G ^b   Brown, L C ^b   Greenhalgh, R M ^b   Hamsten, A ^a   Powell, J T ^b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C; CYSTEINE PROTEINASE; DNA; ENZYME INHIBITOR; SIGNAL PEPTIDE;

ABDOMINAL AORTA ANEURYSM; ADULT; AGE; AGED; ARTICLE; CALCULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; ENZYME INHIBITION; FOLLOW UP; GENETIC POLYMORPHISM; GENOTYPE; GROWTH RATE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SEX; SMOKING;

AGED; AORTIC ANEURYSM, ABDOMINAL; CYSTEINE ENDOPEPTIDASES; GENOTYPE; HOMOZYGOTE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; SMOKING;

EID: 1642580597     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4364     Document Type: Article

References (18)

1. Shah PK. Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation 1997; 96: 2115-2117.
2. Wassef M, Baxter BT, Chisholm RL, Dalman RL, Fillinger MF, Heinecke J et al. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute. J Vasc Surg 2001; 34: 730-738.
3. McMillan WD, Tamarina NA, Cipollone M, Johnson DA, Parker MA, Pearce WH. Size matters: the relationship between MMP-9 expression and aortic diameter. Circulation 1997; 96: 2228-2232.
4. Carrell TW, Burnand KG, Wells GM, Clements JM, Smith A. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 2002; 105: 477-482.
5. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998; 102: 576-583.
6. Shi G-P, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999; 104: 1191-1197.
7. Rawlings ND, Barrett AJ. Evolution of proteins of the cystatin superfamily. J Mol Evol 1990; 30: 60-71.
8. Lindholt JS, Erlandsen EJ, Henneberg EW. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms. Br J Surg 2001; 88: 1472-1475.
9. Balbin M, Abrahamson M. SstII polymorphic sites in the promoter region of the human cystatin C gene. Hum Genet 1991; 87: 751-752.
10. Balbin M, Grubb A, Abrahamson M. An Ala/Thr variation in the coding region of the human cystatin C gene (CST3) detected as a SstII polymorphism. Hum Genet 1993; 92: 206-207.
11. Crawford FC, Freeman MJ, Schinka JA, Abdullah LI, Gold M, Hartman R et al. A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease. Neurology 2000; 55: 763-768.
12. Finckh U, von der Kammer H, Velden J, Michel T, Andresen B, Deng A et al. Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Arch Neurol 2000; 57: 1579-1583.
13. UK Small Aneurysm Trial Participants. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 1998; 352: 1649-1655.
14. Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA et al. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002; 360: 1531-1539.
15. Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA et al. Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial. Multicentre Aneurysm Screening Study Group. BMJ 2002; 325: 1135-1138.
16. Jones K, Powell J, Brown L, Greenhalgh R, Jormsjö S, Eriksson P. The influence of 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene promoter on the incidence, growth and operative risk of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2002; 23: 421-425.
17. Balbin M, Abrahamson M. PCR assay for a polymorphic DdeI site in the promoter region of the human cystatin C gene. Hum Genet 1992; 88: 710.
18. Diggle PJ, Liang K-Y, Zeger SL. Analysis of Longitudinal Data. Oxford University Press: Oxford, 1994.